why am i not losing weight on tirzepatide 5 mg TrimRX Hit a Plateau on Tirzepatide:

Elkind-Hirsch said the findings are encouraging, but more studies are needed to better establish long-term safety and efficacy of GLP-1 receptor agonists for women with PCOS

GLP-1 medications also help slow gastric emptying, which can reduce appetite and lead to weight loss

TRIUMPH-4 confirmed: Retatrutide 28.7% weight loss in Phase 3 (December 2025) final data, not preliminary TRIUMPH-1 confirmed (May 21, 2026): 28.3% average weight loss at 80 weeks in 2,339 patients without diabetes pivotal trial met all primary endpoints TRANSCEND-T2D-1 confirmed (June 2026): -2.0% HbA1c and 16.8% weight loss in type 2 diabetes patients a separate diabetes-specific Phase 3 program Filing timeline updated: Eli Lilly will submit a Biologics License Application (BLA) not an NDA, since retatrutide is a biologic expected Q1 2027 (shifted from the previously estimated Q4 2026) Availability updated: Retatrutide remains investigational

These peptides are rich in specific amino acidsglycine, proline, and hydroxyprolinethat are specifically utilized by the body to support connective tissue and joint health

Semaglutide can interact with diabetes medications and may interfere with the absorption of oral medications, so its essential to discuss all potential interactions